Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-30T21:28:16.787Z Has data issue: false hasContentIssue false
  • English
  • Français

Implications of Postvaccination Hepatitis B Surface Antigenemia in the Management of Exposures to Body Fluids

Published online by Cambridge University Press:  02 January 2015

Ana Martín-Ancel ,
María Luisa Casas  and
Bartolomé Bonet
Ana Martín-Ancel*
Affiliation:
Pediatrics and Neonatology Unit, Fundación Hospital Alcorcón, Madrid, Spain
María Luisa Casas
Affiliation:
Laboratory Unit, Fundación Hospital Alcorcón, Madrid, Spain
Bartolomé Bonet
Affiliation:
Pediatrics and Neonatology Unit, Fundación Hospital Alcorcón, Madrid, Spain
*
Pediatrics and Neonatology Unit, Fundación Hospital Alcorcón, Budapest 1. 28922 Alcorcón, Madrid, Spain
Get access Rights & Permissions [Opens in a new window]

Abstract

A neonate vaccinated against HBV was the source of an occupational exposure to blood. She was tested for hepatitis B surface antigen and found to be positive, leading to unnecessary treatment, retesting, and concern. Evaluation of the infectious status of HBV should rely on other means if vaccination has recently occurred.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 25 , Issue 7 , July 2004 , pp. 611 - 613
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.International Health Care Worker Safety Center, University of Virginia Health System. Annual Number of Occupational Percutaneous Injuries and Mucocutaneous Exposures to Blood or Potentially Infective Biological Substances. Charlottesville, VA: University of Virginia Health System; 1998. Available at www.healthsystem.virginia.edu/internet/epinet/estimates.cfm. Accessed June 15, 2004.Google Scholar
2.Challapalli, M, Slosar, M, Vasa, R, Cunningham, DG. Brief surface antigenemia in newborn infants vaccinated with hepatitis B vaccine. Pediatr Infect Dis J 1993;12:878–879.Google Scholar
3.Bernstein, SR, Krieger, P, Puppala, BL, Costello, M. Incidence and duration of hepatitis B surface antigenemia after neonatal hepatitis B immunization. J Pediatr 1994;125:621–622.Google Scholar
4.Weintraub, Z, Khamaysi, N, Elena, H, Gershtein, V, Orenstein, L, Lahat, N. Transient surface antigenemia in newborn infants vaccinated with Engerix B: occurrence and duration. Pediatr Infect Dis J 1994;13:931–933.Google Scholar
5.Köksal, N, Altinkaya, N, Perk, Y. Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization. Acta Paediatr 1996;85:1501–1502.Google Scholar
6.Katkov, WN, Ault, MJ, Dubin, SB. Absence of hepatitis B surface antigenemia after vaccination. Arch Pathol Lab Med 1989;113:1290.Google Scholar
7.Kloster, B, Kramer, R, Eastlund, T, Grossman, B, Zarvan, B. Hepatitis B surface antigenemia in blood donors following vaccination. Transfusion 1995;35:475–477.Google Scholar
8.Janzen, L, Minuk, GY, Fast, M, Bernstein, KN. Vaccine-induced hepatitis B surface antigen positivity in adult hemodialysis patients: incidental and surveillance data. J Am Soc Nephrol 1996;7:1228–1234.Google Scholar
9.Otag, F, Mert, A, Yilmaz, G. Temporary deferral of blood donors after administration of hepatitis B vaccine. Transfusion 1997;37:880.Google Scholar
10.Santana Rodríguez, OE, Morillas Jarillo, C, Esparza Martín, N, Toledo González, A, Checa Andrés, MD, Martín Sánchez, AM. Transient blood surface antigens of hepatitis B in patients on hemodialysis. Rev Clin Esp 1999;199:198–201.Google Scholar
11.Ly, D, Yee, HF, Brezina, M, Martin, P, Gitnick, G, Saab, S. Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization. Am J Gastroenterol 2002;97:138–141.Google Scholar